Oxcarbazepine in Rapid Benzodiazepine Detoxification
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: This study aims at evaluating the tolerability and efficacy of the antiepileptic drug oxcarbazepine in benzodiazepine detoxification in ten patients. METHODS: In this case study of an inpatient withdrawal program, each of the ten patients was detoxified using oxcarbazepine and completed withdrawal successfully without the occurrence of withdrawal symptoms. The detoxification program followed an outlined dosage scheme with oxcarbazepine increase and benzodiazepine tapering. RESULTS: The rapidity of benzodiazepine detoxification using oxcarbazepine was remarkable, benzodiazepine withdrawal being completed in as little as 11 days. CONCLUSIONS: The results support the assumption that oxcarbazepine is a valuable drug for inpatient benzodiazepine withdrawal programs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, in the same study, 27–45% of patients experienced withdrawal symptoms even while taking propranolol [69].”
From Benzodiazepines: Uses, Dangers, and Clinical Considerations (2021) · cites this paper as [69]
In the citing paper
“The control group and the experimental group had the same dropout rate in this study [69].”
From Benzodiazepines: Uses, Dangers, and Clinical Considerations (2021) · cites this paper as [69]
In the citing paper
“One study found that propranolol attenuated some withdrawal symptoms in patients who stopped taking either diazepam (a long-acting BZD) and those who took lorazepam (a short-acting one) abruptly [69].”
From Benzodiazepines: Uses, Dangers, and Clinical Considerations (2021) · cites this paper as [69]
Citations
Cites
SULLIVAN, J. T., SYKORA, K., SCHNEIDERMAN, J., NARANJO, C. A., & SELLERS, E. M. (1989) · British Journal of Addiction · doi:10.1111/j.1360-0443.1989.tb00737.x · Cited by 1,988 · cited 2×
“the antiepileptic drug OXC in benzodiazepine withdrawal (measured with the CIWA-Ar) (17).”
MethodBenzodiazepine use, abuse, and dependence.
O’Brien, C. P. (2005) · PubMed · Cited by 534
The diagnosis and management of benzodiazepine dependence
Ashton, H. (2005) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000165594.60434.84 · Cited by 455 · cited 1×
“At any rate, if only benzodiazepine intake had been reduced gradually, without the addictive therapy using OXC, benzodiazepine detoxification would have taken 6 to 8 weeks (16, 21).”
BackgroundSafety and Efficacy of Oxcarbazepine: Results of Randomized, Double‐Blind Trials
Beydoun, A. (2000) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.12.152s.35254 · Cited by 252
Oxcarbazepine in Affective and Schizoaffective Disorders
Dietrich, D., Kropp, S., & Emrich, H. (2001) · Pharmacopsychiatry · doi:10.1055/s-2001-18036 · Cited by 198
Schmidt, D., & Elger, C. E. (2004) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2004.07.004 · Cited by 190
Rickels, K., Schweizer, E. E., España, F. G., Case, G. W., DeMartinis, N. A., & Greenblatt, D. J. (1999) · Psychopharmacology · doi:10.1007/s002130050798 · Cited by 83
Martinotti, G., Nicola, M. D., Romanelli, R., Andreoli, S., Pozzi, G., Moroni, N., & Janiri, L. (2007) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.833 · Cited by 73
Oxcarbazepine Treatment of Bipolar Disorder
Ghaemi, S. N., Berv, D. A., Klugman, J., Rosenquist, K. J., & Hsu, D. J. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0813 · Cited by 70
Beydoun, A. A., & Kutluay, E. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.1.59 · Cited by 67
Research works printed but not linked: 5
- O'Brien C P, 2005, J Clin Psychiatry 66, Suppl, 2, 28
- Di Costanzo E, 1992, Minerva Psichiatr, 33, 301
- Hermann D, 2005, Psychopharmakotherap, 12, 97
- Ashton C H, 2002, Drinks, Drugs and Dependence: From Science to Clinical Practice, 197
- Laux G, 1989, Schweiz Med Prax, 78, 779
Cited by
Benzodiazepines: Uses, Dangers, and Clinical Considerations
Edinoff, A. N., Nix, C. A., Hollier, J., Sagrera, C. E., Delacroix, B. M., Abubakar, T., Cornett, E. M., Kaye, A. M., & Kaye, A. D. (2021) · Neurology International · doi:10.3390/neurolint13040059 · Cited by 340
“One study found that propranolol attenuated some withdrawal symptoms in patients who stopped taking either diazepam (a long-acting BZD) and those who took lorazepam (a short-acting one) abruptly [69].”
BackgroundResultInfluentialFluyau, D., Revadigar, N., & Manobianco, B. E. (2018) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125317753340 · Cited by 109
Antiepileptic drugs in the treatment of psychiatric disorders
Kaufman, K. R. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.03.011 · Cited by 113
Quaglio, G., Pattaro, C., Gerra, G., Mathewson, S., Verbanck, P., Des Jarlais, D. C., & Lugoboni, F. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.02.008 · Cited by 48
Review: Adjunctive pharmacologic approaches for benzodiazepine tapers
Welsh, J. W., Tretyak, V., McHugh, R. K., Weiss, R. D., & Bogunovic, O. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.04.028 · Cited by 31
Metadata
- Authors
- Croissant, B., Grosshans, M., Diehl, A., & Mann, K.
- Affiliations
- University of Tübingen (DE)
- Heidelberg University (DE)
- ORCID
- Mann, Karl
- Venue
- The American Journal of Drug and Alcohol Abuse
- Publisher
- Informa UK Limited
- Published
- 2008-01
- Volume
- 34
- Issue
- 5
- Pages
- 534-540
- ISSN
- 0095-2990 (ISSN-L)
- 1097-9891
- OpenAlex
- W2142825266
- Cited by
- 15
- References
- 19
- Citations by year
- 2023: 1 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 2 · 2015: 1 · 2014: 3 · 2012: 1
- FWCI
- 0.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Drug and Alcohol Abuse (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Keywords
- oxcarbazepine, benzodiazepine withdrawal, rapid detoxification, benzodiazepine tapering, antiepileptic drugs, withdrawal symptoms, drug tolerability
- MeSH terms
- Oxcarbazepine, Adult, Aged, 80 and over, Anticonvulsants, Benzodiazepines, Carbamazepine, Female, Follow-Up Studies, Humans, Male, Middle Aged, Substance Withdrawal Syndrome, Time Factors, Substance Abuse Treatment Centers, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oxcarbazepine in Rapid Benzodiazepine Detoxification. https://app.cochat.ai/papers/10.1080/00952990802149021
- The paper
- Croissant, B., Grosshans, M., Diehl, A., & Mann, K. (2008). Oxcarbazepine in Rapid Benzodiazepine Detoxification. The American Journal of Drug and Alcohol Abuse. https://doi.org/10.1080/00952990802149021
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.